Can-Fite Received FDA Positive Response to Psoriasis Pediatric Plan
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- S&P 500 ends down; Apple dips ahead of quarterly report
- Apple beats quarterly estimates for profit and revenue
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
- Goldman data shows hedge funds cut leverage at fastest pace since March
| CAN-FITE BIOPHARMA LTD. (NYSE: CANF) | Delayed: 1.63 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.63 | 52 Week High | $3.89 | |||
| Open | $1.63 | 52 Week Low | $1.85 | |||
| Day High | $1.63 | P/E | N/A | |||
| Day Low | $1.63 | EPS | $0.00 | |||
| Volume | 360 | |||||
| CAN-FITE BIOPHARMA LTD. (NYSE: CANF) | Delayed: 1.63 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.63 | 52 Week High | $3.89 | |||
| Open | $1.63 | 52 Week Low | $1.85 | |||
| Day High | $1.63 | P/E | N/A | |||
| Day Low | $1.63 | EPS | $0.00 | |||
| Volume | 360 | |||||
